{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:31:18Z","timestamp":1758767478768,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.urology.2011.04.023","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T16:27:18Z","timestamp":1308932838000},"page":"386-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utility of Percent Free Prostate-specific Antigen in Repeat Prostate Biopsy"],"prefix":"10.1016","volume":"78","author":[{"given":"Byron H.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian V.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Zaytoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan K.","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Stephen","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2011.04.023_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-5347(05)67993-1","article-title":"A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy","volume":"163","author":"Babaian","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib2","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0022-5347(17)35304-1","article-title":"Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values","volume":"151","author":"Keetch","year":"1994","journal-title":"J Urol."},{"key":"10.1016\/j.urology.2011.04.023_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000283071","article-title":"Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer","volume":"59","author":"Terris","year":"1997","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2011.04.023_bib4","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/S0022-5347(05)64999-3","article-title":"Serial biopsy results in prostate cancer screening study","volume":"167","author":"Roehl","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.juro.2008.03.043","article-title":"A novel nomogram to predict the probability of prostate cancer on repeat biopsy","volume":"180","author":"Benecchi","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1464-410X.2010.09362.x","article-title":"Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling","volume":"106","author":"Moussa","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2011.04.023_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.ju.0000150522.82760.00","article-title":"Validation of a nomogram for predicting positive repeat biopsy for prostate cancer","volume":"173","author":"Yanke","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/01.ju.0000087451.64657.fa","article-title":"A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session","volume":"170","author":"Lopez-Corona","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/jama.1995.03530150038031","article-title":"Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening","volume":"274","author":"Catalona","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2011.04.023_bib10","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.urology.2010.06.072","article-title":"Percentage of free prostate-specific antigen: implications in modern extended scheme prostate biopsy","volume":"77","author":"Lee","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.04.023_bib11","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.urology.2005.10.052","article-title":"A meta-analysis of the performance characteristics of the free prostate-specific antigen test","volume":"67","author":"Lee","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.04.023_bib12","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0022-5347(01)68187-4","article-title":"Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies","volume":"158","author":"Catalona","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0022-5347(05)67711-7","article-title":"Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men","volume":"163","author":"Djavan","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.0919-8172.2003.00605.x","article-title":"Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng\/mL","volume":"10","author":"Okegawa","year":"2003","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib15","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1097\/01.ju.0000119667.86071.e7","article-title":"Predictors of prostate cancer after initial negative systematic 12 core biopsy","volume":"171","author":"Singh","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1442-2042.2004.00843.x","article-title":"Effectiveness of percent free prostate specific antigen as a predictor of prostate cancer detection on repeat biopsy","volume":"11","author":"Uemura","year":"2004","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MOU.0b013e328329a33e","article-title":"Optimal biopsy strategies for the diagnosis and staging of prostate cancer","volume":"19","author":"Patel","year":"2009","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.juro.2007.09.033","article-title":"The 20-core prostate biopsy protocol\u2014a new gold standard?","volume":"179","author":"Ravery","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib19","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.juro.2010.06.137","article-title":"Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer","volume":"184","author":"Lee","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.023_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<104::AID-CNCR15>3.0.CO;2-8","article-title":"The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia","volume":"79","author":"Stephan","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2011.04.023_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.juro.2007.10.057","article-title":"Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors","volume":"179","author":"Yin","year":"2008","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951100416X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042951100416X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:56:20Z","timestamp":1758765380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042951100416X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S009042951100416X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2011.04.023","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of Percent Free Prostate-specific Antigen in Repeat Prostate Biopsy","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2011.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}